Moderna Has Big AI News. Is the Stock a Buy?
(NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this hot technology for years to help it save crucial time in the laboratory.
For example, Moderna uses AI to produce mRNAs for researchers to work with, so they no longer have to create mRNA manually to run experiments.
And last year, it signed a deal with International Business Machines to use its AI and quantum computing tools to advance the biotech's research. CEO Stéphane Bancel has spoken often about his commitment to this technology and even set up an AI academy to educate employees about ways to integrate it into their jobs on a daily basis.
Source Fool.com
Moderna Inc. Aktie
109,12 €
-0,35 %
Moderna Inc. erfreut sich großer Beliebtheit, mit einer hohen Zahl an Buy- und niedriger Zahl an Sell-Einschätzungen.
Ein leicht positives Potenzial wird für Moderna Inc. mit einem Kursziel von 130 € im Vergleich zu 109.12 € gesehen.
